Company intelligence / Profile preview

Nanjing Yaojiankang Pharmaceutical Technology

Nanjing, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Nanjing Yaojiankang Pharmaceutical Technology is a China-based biotechnology company focused on the research and development of innovative small molecule drugs. The company primarily targets therapeutic areas such as infectious diseases and oncology, leveraging its internal R&D capabilities to advance early-stage candidates. Located in the Nanjing Jiangbei New Area, a prominent hub for life sciences, the firm integrates drug discovery with pharmaceutical technology services. Its mission centers on addressing unmet medical needs through the development of high-quality, cost-effective therapeutic solutions.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Nanjing Yaojiankang Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanjing Yaojiankang Pharmaceutical Technology.

Explore the full profile